Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case–control study
We conducted this case–control study to assess the role of vascular endothelial growth factor (VEGF) −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical char...
Saved in:
Published in | Tumor biology Vol. 36; no. 11; pp. 8645 - 8652 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.11.2015
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1010-4283 1423-0380 1423-0380 |
DOI | 10.1007/s13277-015-3431-1 |
Cover
Abstract | We conducted this case–control study to assess the role of vascular endothelial growth factor (VEGF) −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of −2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA + AA genotype of −2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC + CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that −2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population. |
---|---|
AbstractList | We conducted this case-control study to assess the role of vascular endothelial growth factor (VEGF) -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of -2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA + AA genotype of -2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC + CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that -2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population.We conducted this case-control study to assess the role of vascular endothelial growth factor (VEGF) -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of -2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA + AA genotype of -2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC + CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that -2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population. We conducted this case–control study to assess the role of vascular endothelial growth factor (VEGF) −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of −2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA + AA genotype of −2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC + CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that −2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population. We conducted this case-control study to assess the role of vascular endothelial growth factor (VEGF) -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of -2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA+AA genotype of -2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC+CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that -2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population. |
Author | Jiao, Luyang Dong, Yuqian Shen, Beili Zhang, Qunmei Yang, Shujuan Lu, Guangjian |
Author_xml | – sequence: 1 givenname: Guangjian surname: Lu fullname: Lu, Guangjian email: shenbeili_zph@163.com organization: Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University – sequence: 2 givenname: Yuqian surname: Dong fullname: Dong, Yuqian organization: Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University – sequence: 3 givenname: Qunmei surname: Zhang fullname: Zhang, Qunmei organization: Blood Transfusion Room, The First Affiliated Hospital of Xinxiang Medical University – sequence: 4 givenname: Luyang surname: Jiao fullname: Jiao, Luyang organization: Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University – sequence: 5 givenname: Shujuan surname: Yang fullname: Yang, Shujuan organization: Department of Health and Social Behavior, West China School of Public Health, Sichuan University – sequence: 6 givenname: Beili surname: Shen fullname: Shen, Beili organization: Department of Renal Transplantation, Zhengzhou People’s Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26044558$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctqFjEUx4O02Is-gBsJuHEzmtvk4k6KNyjYha5DbtMvdWbymWQq306fwTf0Scz0a0EKdpOcwO93OCf_E3AwpzkA8AyjVxgh8bpgSoToEO47yiju8CNwjBmhHaISHbQaYdQxIukROCnlCjVQKf4YHBGOGOt7eQx-XeTgo6vxOsBrMy4BpqEVxS2jyTDMPtVNGKMZ4WVOP-oGDsbVlOE2jbsp5e0mlqnANMOGwRzLt9XPYW6CC2M7THZxTpMpb6BprxL-_Pzt0lxzGmGpi989AYeDGUt4enufgq_v3305-9idf_7w6ezteecYI7Ujyg8ScYuI4AQrbr003IhgnLJM2J5RRSWXStjBDyJYy733ilFmZd8PtKen4OW-7zan70soVU-xrDOaOaSlaCyYoERRwRv64h56lZbcdrqhFEe0R7JRz2-pxU7B622Ok8k7ffe5DRB7wOVUSg6DdrGaGtftTRw1RnqNUe9j1C0dvcaocTPxPfOu-UMO2TulsfNlyP8M_V_pL1R8sPs |
CitedBy_id | crossref_primary_10_1159_000505817 crossref_primary_10_1186_s41021_021_00185_3 crossref_primary_10_18632_oncotarget_17293 crossref_primary_10_1177_1533034617712396 crossref_primary_10_18632_oncotarget_17833 crossref_primary_10_3389_fphys_2018_00715 crossref_primary_10_1016_j_mgene_2022_101017 crossref_primary_10_1097_MD_0000000000034089 crossref_primary_10_18632_oncotarget_14263 crossref_primary_10_1016_j_gene_2018_09_005 |
Cites_doi | 10.1006/cyto.2000.0692 10.3892/ol.2013.1499 10.1200/JCO.2005.06.081 10.1194/jlr.P030551 10.1093/jnci/djh014 10.1016/j.febslet.2006.03.087 10.1016/j.juro.2010.06.009 10.1155/2014/932481 10.1371/journal.pone.0016982 10.1089/gtmb.2011.0029 10.1007/s13277-013-1173-5 10.3233/CBM-130348 10.1016/j.oraloncology.2012.05.023 10.3892/mmr.2013.1607 10.1002/cncr.20749 10.1007/s12032-014-0193-3 10.1371/journal.pone.0005798 10.1093/aje/kwn122 10.1016/j.humimm.2012.10.014 10.1371/journal.pone.0019773 10.1007/s00384-008-0586-x 10.2337/diacare.17.2.115 10.1016/j.lfs.2006.12.033 10.1007/s13277-013-1475-7 10.1007/s12032-013-0509-8 10.3892/mmr.2014.1890 10.1016/S0002-9440(10)64859-6 10.1038/nrc909 10.7314/APJCP.2014.15.10.4211 10.1016/j.canlet.2003.11.032 10.1093/toxsci/kfm060 10.1093/annonc/mds022 |
ContentType | Journal Article |
Copyright | International Society of Oncology and BioMarkers (ISOBM) 2015 |
Copyright_xml | – notice: International Society of Oncology and BioMarkers (ISOBM) 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7TO 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1007/s13277-015-3431-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Research Library Biological Science Database Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1423-0380 |
EndPage | 8652 |
ExternalDocumentID | 3897217061 26044558 10_1007_s13277_015_3431_1 |
Genre | Journal Article Feature |
GroupedDBID | --- .GJ 06D 0VX 0VY 0~B 123 1N0 203 29Q 29~ 2KM 2LR 2VQ 30V 30W 328 36B 3V. 4.4 408 40D 53G 67N 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8UI 8UJ 96X AAIAL AAJKR AARHV AARTL AASGM AAWCG AAYIC AAYIU AAYQN AAYTO AAYZH AAZMS ABBTS ABJOX ABPLI ABQXT ABTEG ABTHY ABTMW ABUWG ABWCG ACBXY ACGFS ACKNC ACPQW ACPRK ACQXL ADAGL ADBBV ADHIR ADINQ ADKPE ADZMO AEGNC AEJHL AENEX AEOHA AEPYU AETCA AEWDL AEYAO AFBBN AFCOW AFDXO AFKRA AFKRG AFLOW AFRWT AFSIO AFWTZ AFZKB AGAYW AGJBK AGQMX AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIIXL AIOMO AJBLW AJUZI AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP ANMIH AUTPY AYAKG AZQEC BBNVY BCNDV BDDNI BENPR BGNMA BHPHI BPHCQ BSEHC BVXVI CAG CCPQU COF CS3 CSCUP CYUIP DU5 DV7 DWQXO E0A EBD EBS EJD EMB EMOBN EN4 ESBYG F5P FB. FRRFC FYJPI FYUFA GGRSB GNUQQ GQ6 GQ7 GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GUQSH H13 HCIFZ HF~ HMCUK HMJXF HRMNR HZ~ IOS ITM J0Z J8X JBSCW K.F KOV LK8 M1P M2O M4Y M7P N9A NQS NU0 O1H O9- O93 O9I OK1 PADUT PIMPY PQQKQ PROAC PSQYO Q2X R9I RIG RKO ROL RSV RXVBD S1Z S27 S3A S3B SAUOL SBL SFC SHX SOJ SV3 T13 U2A U9L UDS UG4 UJ6 UKHRP VC2 W48 WK8 Z45 ZOVNA ZXP ~A9 0R~ AAYXX ABFSG ACHEB ACSTC AEZWR AFHIU AHWEU AIXLP CITATION PHGZM PHGZT SCNPE CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7T5 7TO 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO |
ID | FETCH-LOGICAL-c442t-29df806b02762196bd8a6a7eac9b47b5439386897bfdf7ebb6ddd9434b855f353 |
IEDL.DBID | AGYKE |
ISSN | 1010-4283 1423-0380 |
IngestDate | Fri Sep 05 02:45:06 EDT 2025 Sat Aug 23 13:38:27 EDT 2025 Mon Jul 21 06:03:36 EDT 2025 Thu Apr 24 23:05:48 EDT 2025 Tue Jul 01 02:37:26 EDT 2025 Fri Feb 21 02:38:40 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Vascular endothelial growth factor Renal cell carcinomas Polymorphism Cancer risk |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c442t-29df806b02762196bd8a6a7eac9b47b5439386897bfdf7ebb6ddd9434b855f353 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/1749603508?pq-origsite=%requestingapplication% |
PMID | 26044558 |
PQID | 1749603508 |
PQPubID | 33651 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1747329376 proquest_journals_1749603508 pubmed_primary_26044558 crossref_citationtrail_10_1007_s13277_015_3431_1 crossref_primary_10_1007_s13277_015_3431_1 springer_journals_10_1007_s13277_015_3431_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-11-01 |
PublicationDateYYYYMMDD | 2015-11-01 |
PublicationDate_xml | – month: 11 year: 2015 text: 2015-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: United States – name: London |
PublicationSubtitle | Tumor Markers, Tumor Targeting and Translational Cancer Research |
PublicationTitle | Tumor biology |
PublicationTitleAbbrev | Tumor Biol |
PublicationTitleAlternate | Tumour Biol |
PublicationYear | 2015 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | ConklinBSZhaoWZhongDSChenCNicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cellsAm J Pathol2002160241381:CAS:528:DC%2BD38XitVClu7g%3D10.1016/S0002-9440(10)64859-6118395601850669 WongHPYuLLamEKTaiEKWuWKChoCHNicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activationToxicol Sci2007972279871:CAS:528:DC%2BD2sXmsV2jurY%3D10.1093/toxsci/kfm06017369603Epub 2007 Mar 16 GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer. 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx Sáenz-LópezPVazquezFCozarJMCarreteroRGarridoFRuiz-CabelloFVEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish populationHum Immunol20137419810310.1016/j.humimm.2012.10.01423073296Epub 2012 Oct 13 PerroneGVincenziBSantiniDCorrelation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinicopathological features in colon cancerCancer Lett2004208227341:CAS:528:DC%2BD2cXktVOls74%3D10.1016/j.canlet.2003.11.03215142682 StathopoulouMGBonnefondANdiayeNCAzimi-NezhadMEl ShamiehSSalehAA common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-CJ Lipid Res.2013542535411:CAS:528:DC%2BC3sXosF2hug%3D%3D10.1194/jlr.P030551232042973546029 AjazSKhaliqSAbidAHassanASHashmiASultanGAssociation of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinomaGenet Test Mol Biomarkers201115965371:CAS:528:DC%2BC3MXhtFKnt7jP10.1089/gtmb.2011.002921491998Epub 2011 Apr 14 IordacheSSaftoiuAGeorgescuCVVascular endothelial growth factor expression and microvessel density—two useful tools for the assessment of prognosis and survival in gastric cancer patientsJ Gastrointestin Liver Dis201019135920593045 WatsonCJWebbNJBottomleyMJBrenchleyPEIdentification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein productionCytokine2000128123251:CAS:528:DC%2BD3cXltlOqsbw%3D10.1006/cyto.2000.069210930302 ZhangYLiSXiaoHQHuZXXuYCHuangQVascular endothelial growth factor gene polymorphisms and renal cell carcinoma: a systematic review and meta-analysisOncol Lett201364106878241374663796421Epub 2013 Jul 29 Sa-NguanraksaDKooptiwutSChuangsuwanichTPongpruttipanTMalasitPO-CharoenratPVascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancerMol Med Rep201493104481:CAS:528:DC%2BC2cXktFers70%3D24401996 BelloccoRPasqualiERotaMBagnardiVTramacereIScottiLAlcohol drinking and risk of renal cell carcinoma: results of a meta-analysisAnn Oncol20122392235441:STN:280:DC%2BC38vlsl2ktA%3D%3D10.1093/annonc/mds02222398178 OuCZhaoHLZhuBHuangLSLiPZLaoMAssociation of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysisJ Recept Signal Transduct Res20141916 JaiswalPKTripathiNShuklaAMittalRDAssociation of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer riskMed Oncol201330250910.1007/s12032-013-0509-823430447Epub 2013 Feb 21 WangZWenPLuoXFangXWangQMaFAssociation of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese populationTumour Biol20143543605101:CAS:528:DC%2BC2cXmtlWktLw%3D10.1007/s13277-013-1475-724310504Epub 2013 Dec 6 FicarraVMartignoniGMaffeiNBrunelliMNovaraGZanollaLOriginal and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinomaCancer20051031687510.1002/cncr.2074915573369 FacchiniFChenYDReavenGMLight-to-moderate alcohol intake is associated with enhanced insulin sensitivityDiabetes Care199417211591:STN:280:DyaK2c7osFCrsQ%3D%3D10.2337/diacare.17.2.1157907975 AdamsKFLeitzmannMFAlbanesDKipnisVMooreSCSchatzkinABody size and renal cell cancer incidence in a large US cohort studyAm J Epidemiol2008168326877185445712727262Epub 2008 Jun 9 EvensenLMicklemDRBloisABergeSVAarsaetherNLittlewood-EvansAMural cell associated VEGF is required for organotypic vessel formationPLoS One20094610.1371/journal.pone.0005798194954222688382 Barbera-GuillemENyhusJKWolfordCCFrieceCRSampselJWVascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the processCancer Res20026223704291:CAS:528:DC%2BD38XpsVahtr8%3D12460925 FerraraNVEGF and the quest for tumour angiogenesis factorsNat Rev Cancer20022107958031:CAS:528:DC%2BD38XnsVGrtbk%3D10.1038/nrc90912360282 Sa-NguanraksaDChuangsuwanichTPongpruttipanTKummalueTRojananinSRatanawichhitrasinAVascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressivenessMol Med Rep2013841242501:CAS:528:DC%2BC3sXhs1elsbvK23904001Epub 2013 Jul 31 AtilganDParlaktasBSUluocakNKolukcuEErdemirFOzyurtHThe relationship between ALA16VAL single gene polymorphism and renal cell carcinomaAdv Urol2014201493248110.1155/2014/932481245877993920972 MuHJZouJXiePXuZQRuanJYangSDAssociation of leptin receptor Lys109Arg and Gln223Arg polymorphisms with increased risk of clear cell renal cell carcinomaAsian Pac J Cancer Prev201415104211510.7314/APJCP.2014.15.10.421124935373 Martinez-FierroMLGarza-VelozIRojas-MartinezAOrtiz-LopezRCastruita-de la RosaCOrtiz-CastroYPositive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancerCancer Biomark2013134235411:CAS:528:DC%2BC3sXhslKgt7fL10.3233/CBM-13034824240584 BruyèreFHovensCMMarsonMNd'ArcierBFCostelloAJWatierHVEGF polymorphisms are associated with an increasing risk of developing renal cell carcinomaJ Urol201018441273810.1016/j.juro.2010.06.00920723915 HicklinDJEllisLMRole of the vascular endothelial growth factor pathway in tumor growth and angiogenesisJ Clin Oncol20052351011271:CAS:528:DC%2BD2MXit1Gnsro%3D10.1200/JCO.2005.06.08115585754 Rinck-JuniorJAOliveiraCLourençoGJSagarraRADerchainSFSegallaJGVascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancerJ Cancer Res Clin Oncol201493813639 VineisPAlavanjaMBufflerPFonthamEFranceschiSGaoYTTobacco and cancer: recent epidemiological evidenceJ Natl Cancer Inst2004962991061:STN:280:DC%2BD2c%2FjsV2rsw%3D%3D10.1093/jnci/djh01414734699 KandaYWatanabeYNicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cellsLife Sci200780151409141:CAS:528:DC%2BD2sXislKgt7g%3D10.1016/j.lfs.2006.12.03317286987Epub 2007 Jan 17 KushnerEJBautchVLBuilding blood vessels in development and diseaseCurr Opin Hematol2013203231623567339 SupicGJovicNZeljicKKozomaraRMagicZAssociation of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patientsOral Oncol20124811117171:CAS:528:DC%2BC38XhtV2itLjN10.1016/j.oraloncology.2012.05.02322818823Epub 2012 Jul 18 HongTTCaiDYWuXHHuaDThree vascular endothelial growth factor polymorphisms (−460C > T, −2578C > A, 1612G > A) with cancer risk: a meta-analysis based on 30 case–control studiesCancer Invest201129747271:CAS:528:DC%2BC3MXos1Grt7s%3D21740084 AndersenSDonnemTAl-ShibliKAl-SaadSStenvoldHBusundLTPrognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2PLoS One201165e197731:CAS:528:DC%2BC3MXmsFGktbk%3D10.1371/journal.pone.0019773216036283095634 StefanouDBatistatouAKaminaSExpression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancerIn Vivo200418155601:CAS:528:DC%2BD2cXjslGjsro%3D15113042 MaltesePCanestrariERuzzoAGrazianoFFalconeALoupakisFVEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian populationInt J Colorectal Dis20092421657010.1007/s00384-008-0586-x18830612Epub 2008 Oct 2 RahouiJLaraquiASbittiYTouilNIbrahimiAGhrabBInvestigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case–control studyMed Oncol201431919310.1007/s12032-014-0193-325148899Epub 2014 Aug 23 RoyHBhardwajSYlä-HerttualaSBiology of vascular endothelial growth factorsFEBS Lett2006580122879871:CAS:528:DC%2BD28XltVKnt7g%3D10.1016/j.febslet.2006.03.08716631753Epub 2006 Apr 17 RuggieroDDalmassoCNutileTSoriceRDionisiLAversanoMGenetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphismsPLoS One201162e169821:CAS:528:DC%2BC3MXitlyjtbo%3D10.1371/journal.pone.0016982213473903036731 XuYZhuSAssociations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysisTumour Biol20143521307111:CAS:528:DC%2BC2cXjtlCqtbw%3D10.1007/s13277-013-1173-524127038Epub 2013 Oct 15 R Bellocco (3431_CR3) 2012; 23 D Ruggiero (3431_CR15) 2011; 6 E Barbera-Guillem (3431_CR9) 2002; 62 Y Kanda (3431_CR39) 2007; 80 D Atilgan (3431_CR8) 2014; 2014 N Ferrara (3431_CR11) 2002; 2 P Sáenz-López (3431_CR21) 2013; 74 V Ficarra (3431_CR24) 2005; 103 EJ Kushner (3431_CR25) 2013; 20 BS Conklin (3431_CR38) 2002; 160 HJ Mu (3431_CR6) 2014; 15 S Andersen (3431_CR13) 2011; 6 S Iordache (3431_CR27) 2010; 19 G Supic (3431_CR36) 2012; 48 Y Zhang (3431_CR23) 2013; 6 Y Xu (3431_CR34) 2014; 35 D Stefanou (3431_CR29) 2004; 18 CJ Watson (3431_CR14) 2000; 12 TT Hong (3431_CR37) 2011; 29 J Rahoui (3431_CR31) 2014; 31 PK Jaiswal (3431_CR33) 2013; 30 HP Wong (3431_CR40) 2007; 97 H Roy (3431_CR26) 2006; 580 D Sa-Nguanraksa (3431_CR19) 2014; 9 L Evensen (3431_CR10) 2009; 4 P Vineis (3431_CR2) 2004; 96 D Sa-Nguanraksa (3431_CR35) 2013; 8 ML Martinez-Fierro (3431_CR17) 2013; 13 3431_CR1 C Ou (3431_CR7) 2014; 19 Z Wang (3431_CR18) 2014; 35 F Bruyère (3431_CR22) 2010; 184 JA Rinck-Junior (3431_CR16) 2014; 93 DJ Hicklin (3431_CR12) 2005; 23 F Facchini (3431_CR5) 1994; 17 S Ajaz (3431_CR20) 2011; 15 G Perrone (3431_CR28) 2004; 208 MG Stathopoulou (3431_CR30) 2013; 54 KF Adams (3431_CR4) 2008; 168 P Maltese (3431_CR32) 2009; 24 18830612 - Int J Colorectal Dis. 2009 Feb;24(2):165-70 24310504 - Tumour Biol. 2014 Apr;35(4):3605-10 24240584 - Cancer Biomark. 2013;13(4):235-41 21603628 - PLoS One. 2011;6(5):e19773 23073296 - Hum Immunol. 2013 Jan;74(1):98-103 24137466 - Oncol Lett. 2013 Oct;6(4):1068-1078 15573369 - Cancer. 2005 Jan 1;103(1):68-75 12460925 - Cancer Res. 2002 Dec 1;62(23):7042-9 22398178 - Ann Oncol. 2012 Sep;23(9):2235-44 18544571 - Am J Epidemiol. 2008 Aug 1;168(3):268-77 15585754 - J Clin Oncol. 2005 Feb 10;23(5):1011-27 23204297 - J Lipid Res. 2013 Feb;54(2):535-41 23567339 - Curr Opin Hematol. 2013 May;20(3):231-6 24840096 - J Recept Signal Transduct Res. 2014 Dec;34(6):463-8 21347390 - PLoS One. 2011 Feb 09;6(2):e16982 14734699 - J Natl Cancer Inst. 2004 Jan 21;96(2):99-106 22818823 - Oral Oncol. 2012 Nov;48(11):1171-7 24401996 - Mol Med Rep. 2014 Mar;9(3):1044-8 24935373 - Asian Pac J Cancer Prev. 2014;15(10):4211-5 12360282 - Nat Rev Cancer. 2002 Oct;2(10):795-803 25148899 - Med Oncol. 2014 Sep;31(9):193 15113042 - In Vivo. 2004 Mar-Apr;18(2):155-60 20723915 - J Urol. 2010 Oct;184(4):1273-8 19495422 - PLoS One. 2009 Jun 04;4(6):e5798 23430447 - Med Oncol. 2013 Jun;30(2):509 23904001 - Mol Med Rep. 2013 Oct;8(4):1242-50 24127038 - Tumour Biol. 2014 Feb;35(2):1307-11 21740084 - Cancer Invest. 2011 Aug;29(7):472-7 16631753 - FEBS Lett. 2006 May 22;580(12):2879-87 15142682 - Cancer Lett. 2004 May 28;208(2):227-34 17369603 - Toxicol Sci. 2007 Jun;97(2):279-87 10930302 - Cytokine. 2000 Aug;12(8):1232-5 20593045 - J Gastrointestin Liver Dis. 2010 Jun;19(2):135-9 7907975 - Diabetes Care. 1994 Feb;17(2):115-9 21491998 - Genet Test Mol Biomarkers. 2011 Sep;15(9):653-7 17286987 - Life Sci. 2007 Mar 20;80(15):1409-14 11839560 - Am J Pathol. 2002 Feb;160(2):413-8 24587799 - Adv Urol. 2014;2014:932481 |
References_xml | – reference: WangZWenPLuoXFangXWangQMaFAssociation of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese populationTumour Biol20143543605101:CAS:528:DC%2BC2cXmtlWktLw%3D10.1007/s13277-013-1475-724310504Epub 2013 Dec 6 – reference: IordacheSSaftoiuAGeorgescuCVVascular endothelial growth factor expression and microvessel density—two useful tools for the assessment of prognosis and survival in gastric cancer patientsJ Gastrointestin Liver Dis201019135920593045 – reference: Sáenz-LópezPVazquezFCozarJMCarreteroRGarridoFRuiz-CabelloFVEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish populationHum Immunol20137419810310.1016/j.humimm.2012.10.01423073296Epub 2012 Oct 13 – reference: JaiswalPKTripathiNShuklaAMittalRDAssociation of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer riskMed Oncol201330250910.1007/s12032-013-0509-823430447Epub 2013 Feb 21 – reference: WongHPYuLLamEKTaiEKWuWKChoCHNicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activationToxicol Sci2007972279871:CAS:528:DC%2BD2sXmsV2jurY%3D10.1093/toxsci/kfm06017369603Epub 2007 Mar 16 – reference: RoyHBhardwajSYlä-HerttualaSBiology of vascular endothelial growth factorsFEBS Lett2006580122879871:CAS:528:DC%2BD28XltVKnt7g%3D10.1016/j.febslet.2006.03.08716631753Epub 2006 Apr 17 – reference: MuHJZouJXiePXuZQRuanJYangSDAssociation of leptin receptor Lys109Arg and Gln223Arg polymorphisms with increased risk of clear cell renal cell carcinomaAsian Pac J Cancer Prev201415104211510.7314/APJCP.2014.15.10.421124935373 – reference: Sa-NguanraksaDKooptiwutSChuangsuwanichTPongpruttipanTMalasitPO-CharoenratPVascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancerMol Med Rep201493104481:CAS:528:DC%2BC2cXktFers70%3D24401996 – reference: KandaYWatanabeYNicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cellsLife Sci200780151409141:CAS:528:DC%2BD2sXislKgt7g%3D10.1016/j.lfs.2006.12.03317286987Epub 2007 Jan 17 – reference: FerraraNVEGF and the quest for tumour angiogenesis factorsNat Rev Cancer20022107958031:CAS:528:DC%2BD38XnsVGrtbk%3D10.1038/nrc90912360282 – reference: RahouiJLaraquiASbittiYTouilNIbrahimiAGhrabBInvestigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case–control studyMed Oncol201431919310.1007/s12032-014-0193-325148899Epub 2014 Aug 23 – reference: StathopoulouMGBonnefondANdiayeNCAzimi-NezhadMEl ShamiehSSalehAA common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-CJ Lipid Res.2013542535411:CAS:528:DC%2BC3sXosF2hug%3D%3D10.1194/jlr.P030551232042973546029 – reference: SupicGJovicNZeljicKKozomaraRMagicZAssociation of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patientsOral Oncol20124811117171:CAS:528:DC%2BC38XhtV2itLjN10.1016/j.oraloncology.2012.05.02322818823Epub 2012 Jul 18 – reference: AjazSKhaliqSAbidAHassanASHashmiASultanGAssociation of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinomaGenet Test Mol Biomarkers201115965371:CAS:528:DC%2BC3MXhtFKnt7jP10.1089/gtmb.2011.002921491998Epub 2011 Apr 14 – reference: StefanouDBatistatouAKaminaSExpression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancerIn Vivo200418155601:CAS:528:DC%2BD2cXjslGjsro%3D15113042 – reference: RuggieroDDalmassoCNutileTSoriceRDionisiLAversanoMGenetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphismsPLoS One201162e169821:CAS:528:DC%2BC3MXitlyjtbo%3D10.1371/journal.pone.0016982213473903036731 – reference: AndersenSDonnemTAl-ShibliKAl-SaadSStenvoldHBusundLTPrognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2PLoS One201165e197731:CAS:528:DC%2BC3MXmsFGktbk%3D10.1371/journal.pone.0019773216036283095634 – reference: WatsonCJWebbNJBottomleyMJBrenchleyPEIdentification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein productionCytokine2000128123251:CAS:528:DC%2BD3cXltlOqsbw%3D10.1006/cyto.2000.069210930302 – reference: PerroneGVincenziBSantiniDCorrelation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinicopathological features in colon cancerCancer Lett2004208227341:CAS:528:DC%2BD2cXktVOls74%3D10.1016/j.canlet.2003.11.03215142682 – reference: HongTTCaiDYWuXHHuaDThree vascular endothelial growth factor polymorphisms (−460C > T, −2578C > A, 1612G > A) with cancer risk: a meta-analysis based on 30 case–control studiesCancer Invest201129747271:CAS:528:DC%2BC3MXos1Grt7s%3D21740084 – reference: EvensenLMicklemDRBloisABergeSVAarsaetherNLittlewood-EvansAMural cell associated VEGF is required for organotypic vessel formationPLoS One20094610.1371/journal.pone.0005798194954222688382 – reference: BruyèreFHovensCMMarsonMNd'ArcierBFCostelloAJWatierHVEGF polymorphisms are associated with an increasing risk of developing renal cell carcinomaJ Urol201018441273810.1016/j.juro.2010.06.00920723915 – reference: GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer. 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx – reference: KushnerEJBautchVLBuilding blood vessels in development and diseaseCurr Opin Hematol2013203231623567339 – reference: FicarraVMartignoniGMaffeiNBrunelliMNovaraGZanollaLOriginal and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinomaCancer20051031687510.1002/cncr.2074915573369 – reference: MaltesePCanestrariERuzzoAGrazianoFFalconeALoupakisFVEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian populationInt J Colorectal Dis20092421657010.1007/s00384-008-0586-x18830612Epub 2008 Oct 2 – reference: Martinez-FierroMLGarza-VelozIRojas-MartinezAOrtiz-LopezRCastruita-de la RosaCOrtiz-CastroYPositive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancerCancer Biomark2013134235411:CAS:528:DC%2BC3sXhslKgt7fL10.3233/CBM-13034824240584 – reference: XuYZhuSAssociations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysisTumour Biol20143521307111:CAS:528:DC%2BC2cXjtlCqtbw%3D10.1007/s13277-013-1173-524127038Epub 2013 Oct 15 – reference: Rinck-JuniorJAOliveiraCLourençoGJSagarraRADerchainSFSegallaJGVascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancerJ Cancer Res Clin Oncol201493813639 – reference: AdamsKFLeitzmannMFAlbanesDKipnisVMooreSCSchatzkinABody size and renal cell cancer incidence in a large US cohort studyAm J Epidemiol2008168326877185445712727262Epub 2008 Jun 9 – reference: BelloccoRPasqualiERotaMBagnardiVTramacereIScottiLAlcohol drinking and risk of renal cell carcinoma: results of a meta-analysisAnn Oncol20122392235441:STN:280:DC%2BC38vlsl2ktA%3D%3D10.1093/annonc/mds02222398178 – reference: ZhangYLiSXiaoHQHuZXXuYCHuangQVascular endothelial growth factor gene polymorphisms and renal cell carcinoma: a systematic review and meta-analysisOncol Lett201364106878241374663796421Epub 2013 Jul 29 – reference: Sa-NguanraksaDChuangsuwanichTPongpruttipanTKummalueTRojananinSRatanawichhitrasinAVascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressivenessMol Med Rep2013841242501:CAS:528:DC%2BC3sXhs1elsbvK23904001Epub 2013 Jul 31 – reference: FacchiniFChenYDReavenGMLight-to-moderate alcohol intake is associated with enhanced insulin sensitivityDiabetes Care199417211591:STN:280:DyaK2c7osFCrsQ%3D%3D10.2337/diacare.17.2.1157907975 – reference: AtilganDParlaktasBSUluocakNKolukcuEErdemirFOzyurtHThe relationship between ALA16VAL single gene polymorphism and renal cell carcinomaAdv Urol2014201493248110.1155/2014/932481245877993920972 – reference: VineisPAlavanjaMBufflerPFonthamEFranceschiSGaoYTTobacco and cancer: recent epidemiological evidenceJ Natl Cancer Inst2004962991061:STN:280:DC%2BD2c%2FjsV2rsw%3D%3D10.1093/jnci/djh01414734699 – reference: OuCZhaoHLZhuBHuangLSLiPZLaoMAssociation of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysisJ Recept Signal Transduct Res20141916 – reference: ConklinBSZhaoWZhongDSChenCNicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cellsAm J Pathol2002160241381:CAS:528:DC%2BD38XitVClu7g%3D10.1016/S0002-9440(10)64859-6118395601850669 – reference: Barbera-GuillemENyhusJKWolfordCCFrieceCRSampselJWVascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the processCancer Res20026223704291:CAS:528:DC%2BD38XpsVahtr8%3D12460925 – reference: HicklinDJEllisLMRole of the vascular endothelial growth factor pathway in tumor growth and angiogenesisJ Clin Oncol20052351011271:CAS:528:DC%2BD2MXit1Gnsro%3D10.1200/JCO.2005.06.08115585754 – volume: 12 start-page: 1232 issue: 8 year: 2000 ident: 3431_CR14 publication-title: Cytokine doi: 10.1006/cyto.2000.0692 – volume: 6 start-page: 1068 issue: 4 year: 2013 ident: 3431_CR23 publication-title: Oncol Lett doi: 10.3892/ol.2013.1499 – volume: 23 start-page: 1011 issue: 5 year: 2005 ident: 3431_CR12 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.06.081 – volume: 62 start-page: 7042 issue: 23 year: 2002 ident: 3431_CR9 publication-title: Cancer Res – volume: 54 start-page: 535 issue: 2 year: 2013 ident: 3431_CR30 publication-title: J Lipid Res. doi: 10.1194/jlr.P030551 – volume: 29 start-page: 472 issue: 7 year: 2011 ident: 3431_CR37 publication-title: Cancer Invest – volume: 96 start-page: 99 issue: 2 year: 2004 ident: 3431_CR2 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djh014 – volume: 580 start-page: 2879 issue: 12 year: 2006 ident: 3431_CR26 publication-title: FEBS Lett doi: 10.1016/j.febslet.2006.03.087 – volume: 184 start-page: 1273 issue: 4 year: 2010 ident: 3431_CR22 publication-title: J Urol doi: 10.1016/j.juro.2010.06.009 – volume: 2014 start-page: 932481 year: 2014 ident: 3431_CR8 publication-title: Adv Urol doi: 10.1155/2014/932481 – volume: 6 start-page: e16982 issue: 2 year: 2011 ident: 3431_CR15 publication-title: PLoS One doi: 10.1371/journal.pone.0016982 – volume: 15 start-page: 653 issue: 9 year: 2011 ident: 3431_CR20 publication-title: Genet Test Mol Biomarkers doi: 10.1089/gtmb.2011.0029 – ident: 3431_CR1 – volume: 35 start-page: 1307 issue: 2 year: 2014 ident: 3431_CR34 publication-title: Tumour Biol doi: 10.1007/s13277-013-1173-5 – volume: 13 start-page: 235 issue: 4 year: 2013 ident: 3431_CR17 publication-title: Cancer Biomark doi: 10.3233/CBM-130348 – volume: 48 start-page: 1171 issue: 11 year: 2012 ident: 3431_CR36 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2012.05.023 – volume: 8 start-page: 1242 issue: 4 year: 2013 ident: 3431_CR35 publication-title: Mol Med Rep doi: 10.3892/mmr.2013.1607 – volume: 103 start-page: 68 issue: 1 year: 2005 ident: 3431_CR24 publication-title: Cancer doi: 10.1002/cncr.20749 – volume: 31 start-page: 193 issue: 9 year: 2014 ident: 3431_CR31 publication-title: Med Oncol doi: 10.1007/s12032-014-0193-3 – volume: 4 issue: 6 year: 2009 ident: 3431_CR10 publication-title: PLoS One doi: 10.1371/journal.pone.0005798 – volume: 18 start-page: 155 year: 2004 ident: 3431_CR29 publication-title: In Vivo – volume: 168 start-page: 268 issue: 3 year: 2008 ident: 3431_CR4 publication-title: Am J Epidemiol doi: 10.1093/aje/kwn122 – volume: 74 start-page: 98 issue: 1 year: 2013 ident: 3431_CR21 publication-title: Hum Immunol doi: 10.1016/j.humimm.2012.10.014 – volume: 6 start-page: e19773 issue: 5 year: 2011 ident: 3431_CR13 publication-title: PLoS One doi: 10.1371/journal.pone.0019773 – volume: 24 start-page: 165 issue: 2 year: 2009 ident: 3431_CR32 publication-title: Int J Colorectal Dis doi: 10.1007/s00384-008-0586-x – volume: 17 start-page: 115 issue: 2 year: 1994 ident: 3431_CR5 publication-title: Diabetes Care doi: 10.2337/diacare.17.2.115 – volume: 80 start-page: 1409 issue: 15 year: 2007 ident: 3431_CR39 publication-title: Life Sci doi: 10.1016/j.lfs.2006.12.033 – volume: 35 start-page: 3605 issue: 4 year: 2014 ident: 3431_CR18 publication-title: Tumour Biol doi: 10.1007/s13277-013-1475-7 – volume: 19 start-page: 135 year: 2010 ident: 3431_CR27 publication-title: J Gastrointestin Liver Dis – volume: 30 start-page: 509 issue: 2 year: 2013 ident: 3431_CR33 publication-title: Med Oncol doi: 10.1007/s12032-013-0509-8 – volume: 9 start-page: 1044 issue: 3 year: 2014 ident: 3431_CR19 publication-title: Mol Med Rep doi: 10.3892/mmr.2014.1890 – volume: 160 start-page: 413 issue: 2 year: 2002 ident: 3431_CR38 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64859-6 – volume: 93 start-page: 1363 issue: 8 year: 2014 ident: 3431_CR16 publication-title: J Cancer Res Clin Oncol – volume: 2 start-page: 795 issue: 10 year: 2002 ident: 3431_CR11 publication-title: Nat Rev Cancer doi: 10.1038/nrc909 – volume: 15 start-page: 4211 issue: 10 year: 2014 ident: 3431_CR6 publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2014.15.10.4211 – volume: 208 start-page: 227 year: 2004 ident: 3431_CR28 publication-title: Cancer Lett doi: 10.1016/j.canlet.2003.11.032 – volume: 19 start-page: 1 year: 2014 ident: 3431_CR7 publication-title: J Recept Signal Transduct Res – volume: 97 start-page: 279 issue: 2 year: 2007 ident: 3431_CR40 publication-title: Toxicol Sci doi: 10.1093/toxsci/kfm060 – volume: 23 start-page: 2235 issue: 9 year: 2012 ident: 3431_CR3 publication-title: Ann Oncol doi: 10.1093/annonc/mds022 – volume: 20 start-page: 231 issue: 3 year: 2013 ident: 3431_CR25 publication-title: Curr Opin Hematol – reference: 24840096 - J Recept Signal Transduct Res. 2014 Dec;34(6):463-8 – reference: 24127038 - Tumour Biol. 2014 Feb;35(2):1307-11 – reference: 21603628 - PLoS One. 2011;6(5):e19773 – reference: 24137466 - Oncol Lett. 2013 Oct;6(4):1068-1078 – reference: 15142682 - Cancer Lett. 2004 May 28;208(2):227-34 – reference: 20593045 - J Gastrointestin Liver Dis. 2010 Jun;19(2):135-9 – reference: 24240584 - Cancer Biomark. 2013;13(4):235-41 – reference: 22398178 - Ann Oncol. 2012 Sep;23(9):2235-44 – reference: 14734699 - J Natl Cancer Inst. 2004 Jan 21;96(2):99-106 – reference: 18830612 - Int J Colorectal Dis. 2009 Feb;24(2):165-70 – reference: 15113042 - In Vivo. 2004 Mar-Apr;18(2):155-60 – reference: 18544571 - Am J Epidemiol. 2008 Aug 1;168(3):268-77 – reference: 24401996 - Mol Med Rep. 2014 Mar;9(3):1044-8 – reference: 7907975 - Diabetes Care. 1994 Feb;17(2):115-9 – reference: 16631753 - FEBS Lett. 2006 May 22;580(12):2879-87 – reference: 15585754 - J Clin Oncol. 2005 Feb 10;23(5):1011-27 – reference: 19495422 - PLoS One. 2009 Jun 04;4(6):e5798 – reference: 23567339 - Curr Opin Hematol. 2013 May;20(3):231-6 – reference: 12360282 - Nat Rev Cancer. 2002 Oct;2(10):795-803 – reference: 25148899 - Med Oncol. 2014 Sep;31(9):193 – reference: 17286987 - Life Sci. 2007 Mar 20;80(15):1409-14 – reference: 23204297 - J Lipid Res. 2013 Feb;54(2):535-41 – reference: 17369603 - Toxicol Sci. 2007 Jun;97(2):279-87 – reference: 23904001 - Mol Med Rep. 2013 Oct;8(4):1242-50 – reference: 24935373 - Asian Pac J Cancer Prev. 2014;15(10):4211-5 – reference: 21347390 - PLoS One. 2011 Feb 09;6(2):e16982 – reference: 12460925 - Cancer Res. 2002 Dec 1;62(23):7042-9 – reference: 21491998 - Genet Test Mol Biomarkers. 2011 Sep;15(9):653-7 – reference: 24587799 - Adv Urol. 2014;2014:932481 – reference: 15573369 - Cancer. 2005 Jan 1;103(1):68-75 – reference: 11839560 - Am J Pathol. 2002 Feb;160(2):413-8 – reference: 23073296 - Hum Immunol. 2013 Jan;74(1):98-103 – reference: 10930302 - Cytokine. 2000 Aug;12(8):1232-5 – reference: 21740084 - Cancer Invest. 2011 Aug;29(7):472-7 – reference: 20723915 - J Urol. 2010 Oct;184(4):1273-8 – reference: 24310504 - Tumour Biol. 2014 Apr;35(4):3605-10 – reference: 22818823 - Oral Oncol. 2012 Nov;48(11):1171-7 – reference: 23430447 - Med Oncol. 2013 Jun;30(2):509 |
SSID | ssj0015996 |
Score | 2.153465 |
Snippet | We conducted this case–control study to assess the role of vascular endothelial growth factor (VEGF) −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C... We conducted this case-control study to assess the role of vascular endothelial growth factor (VEGF) -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 8645 |
SubjectTerms | Adult Aged Asian Continental Ancestry Group Biomedical and Life Sciences Biomedicine Cancer Research Carcinoma, Renal Cell - genetics Carcinoma, Renal Cell - pathology Case studies Female Genetic Association Studies Genetic Predisposition to Disease Genetic Testing Genotype Humans Kidney cancer Male Middle Aged Polymorphism Prognosis Research Article Risk assessment Risk Factors Vascular Endothelial Growth Factor A - genetics |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Na9RAFH_YCq0X0Vp1dZURPFmGbpL5SLyIFEsRKh4s7C1kvmphm6yb7cGT_7rvzU52K4t7S8hMMsx7ed_zewDvAyrFqmosz10wXFjX8EpYxYOyZVXm2riGAvqX39TFlfg6ldMUcOtTWeUgE6Ogdp2lGPkpWs5obBdoT3ya_-LUNYqyq6mFxh48jNBlyM96una4MoIeidlOlDUELDZkNePRuYKSlziGF6hDefavXtoyNrcSpVH_nD-Bx8lwZJ9XlH4KD3x7BIdnQ7-2Izi4TGnyZ_Dn-4KuSZIxQvP2rAtsqDllvnV07GqGnMeu0Qtf_mSrrjts3s1-33a48zf9bc-6luEwRsXnNH_h6fsU6GeWGhC1VFn0kTV413ueSt5ZhKs9hqvzLz_OLnjqtMCtEPmS55UL5UQZ9FEVijBlXNmoRqNQrozQRqLVUpSqrLQJLmhvjHLOEbKcKaUMhSyew37btf4lMCO89n6CM70SThVGemUzk9tgssZJP4LJsM-1TTDk1A1jVm8AlIk0NZKmJtLU2Qg-rKfMVxgcuwaPB-LV6Xfs6w3zjODd-jHShzataX13F8foAo0frUbwYkX09dfQ6RNCSpx9MnDBvZf_bymvdi_lNTzKif_iwcYx7C8Xd_4NWjhL8zay8V-fufhz priority: 102 providerName: ProQuest |
Title | Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case–control study |
URI | https://link.springer.com/article/10.1007/s13277-015-3431-1 https://www.ncbi.nlm.nih.gov/pubmed/26044558 https://www.proquest.com/docview/1749603508 https://www.proquest.com/docview/1747329376 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB5BKkEvPAqUQKkWiRPIVWzvw-YWopQK1KpCjRROlvdVEKldxc4BTvAb-If8Emb8SIECUi9-7q7t3dl5eGa_AXjmUSimaW6CyHodcGPzIOVGBl6aJE0ipW1OP_QPj-TBjL-Zi3m3jrvqo917l2TDqS8Wu8XkbkTxFcQo9QI0eTZEiA0OYGP8-v3b6dp5QIgjjZMTWQzhifXOzL818rs4uqRjXvKPNmJn_zac9C_cRpt82lvVes98-QPL8YpfdAdudWooG7d0cxeuuWILbk767G9bcOOwc7rfg2_HSzomvsgIG9yx0rM-gpW5wtIirgXSMTtFm77-wNocPuy8XHw-K3EcP1ZnFSsLhsUYhbJT_aWj55PbgBlKZ1RQnNJLluNZ5X58_d6F0LMG_vY-zPanJ5ODoMvcEBjOozqIUuuTkdRo80pkiVLbJJe5Qiafaq60QC0oTmSSKu2tV05raa0lpDqdCOFjET-AQVEW7iEwzZ1yboQ1neRWxlo4aUIdGa_D3Ao3hFE_gJnpYM0pu8YiuwBkpm7OsJsz6uYsHMLzdZXzFtPjf4V3eqrIuuldZWjGoeUXo3I7hKfr2zhC1G154cpVU0bFqEwpOYTtlprWT0MjknMhsPaLnjJ-afxfr_LoSqUfw2ZEpNWsm9yBQb1cuSeoQNV6F66rucJtMgl3u8mD-1fTo-N3eHUWjX8C7-AXyQ |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEB7CBpJeSpO-No9GhfbSIrpry7JdKKV5sWmySygJ5OZYrzawsTfrDSWn_qP-xs7Y1qYlNLfcbCxZQt9oZqR5AbxxKBTTNNc8ME5xoU3OU6Eld1InaRLEyuR0oT8cycGp-HoWnS3Abx8LQ26VnifWjNqUmu7IP6DmjMp2iPrE58kVp6pRZF31JTQasji0Nz_xyFZ9OthFfN8Gwf7eyc6At1UFuBYimPEgNS7pSYXnMYnbVSqT5DKPkQGlSsQqQgkdJjJJY-WMi61S0hhDWdRUEkWurhKBLH9RUERrBxa390bH3-Z2C0p2UttXkbtRKjNvR62D9UIyl2IbHqLU5v1_JeEd9faOabaWePtP4HGrqrIvDW2twIItVmF5x1eIW4WlYWuYfwq_jqf0TLyTUf5wy0rHvJcrs4WhQK8x0jr7juf-2Q_W1Plhk3J8c1ki1hfVZcXKgmEzRu7u1H9qaXwyLTBNJY8K8mX6yHJ8qyxvnexZnSD3GZw-CArPoVOUhX0JTAkbW9vDnlYKI0MVWan7KtBO9XMT2S70_Dpnuk18TvU3xtltymaCJkNoMoIm63fh3bzLpMn6cV_jDQ9e1jKAKrsl1y68nn9GfGjR8sKW13WbOER1K5ZdeNGAPh8Nj5lCRBH2fu-p4K-f_28qa_dPZQuWByfDo-zoYHS4Do8CosU6rHIDOrPptd1E_WqmXrVEzeD8offRH90NNuE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB4hKgGXqrzabXm4Eqcii93EdhJuCFjxFoeuxC2KX22lJVltwqG39jf0H_aXMJPHUgRU4pYoYyfyTObhGX8DsOPRKCZJZnhgvebC2IwnwijulYmTOIi0zWhD__JKnYzE2Y28afucll21e5eSbM40EEpTXu1NrN97OPgWUuoRTRkP0QJyDH_eoDYekKCPgoNZGoGwR-p0JyobQhbr0prPTfHYMD3xNp9kSmsDNHwHb1vPkR00rF6GOZevwOJh17BtBRYu2zz5Kvy-ntI1qTJGcN6OFZ51RafM5ZbOXY1R9Ng3DMOr76xpu8MmxfjnbYFL_6O8LVmRMyRjVH1O46eO3k87_cxQB6KcSov2WYZ3pfv7609b9c5qxNo1GA2Pvx6e8LbZAjdCBBUPEuvjvtIYpirUYkrbOFNZhHo50SLSEh2XMFZxEmlvfeS0VtZaApfTsZQ-lOE6zOdF7j4A08JFzvVxpFPCqlBLp8xAB8brQWal60G_W-nUtEjk1BBjnD5gKBNzUmROSsxJBz34MhsyaWA4_ke80bEvbf_IMsXIC4O1EP3RHnyePUYO0bJluSvuapooRP8nUj1437B99jaM-4SQEkfvdnLwz-QvfcrHV1Fvw8L10TC9OL06_wRLAclmfepxA-ar6Z3bRPen0lu1iN8DIbH93w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictive+value+of+vascular+endothelial+growth+factor+polymorphisms+on+the+risk+of+renal+cell+carcinomas%3A+a+case%E2%80%93control+study&rft.jtitle=Tumor+biology&rft.au=Lu%2C+Guangjian&rft.au=Dong%2C+Yuqian&rft.au=Zhang%2C+Qunmei&rft.au=Jiao%2C+Luyang&rft.date=2015-11-01&rft.issn=1010-4283&rft.eissn=1423-0380&rft.volume=36&rft.issue=11&rft.spage=8645&rft.epage=8652&rft_id=info:doi/10.1007%2Fs13277-015-3431-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s13277_015_3431_1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1010-4283&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1010-4283&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1010-4283&client=summon |